Update on male circumcision: Prevention success and challenges ahead

Current Infectious Disease Reports

Volumn 10, Issue 3, 2008, Pages 243-251

  Johnson, Kristine E ^a   Quinn, Thomas C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CHLAMYDIASIS; CIRCUMCISION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CULTURAL ANTHROPOLOGY; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH PROMOTION; HERPES SIMPLEX; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RISK; NONHUMAN; PERSONAL HYGIENE; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; RURAL POPULATION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL BELIEF; SURGICAL RISK; TRICHOMONIASIS; UNSAFE SEX; URBAN POPULATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 56349097278     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0040-9     Document Type: Review

References (58)

1. O'Farrell N: Soap and water prophylaxis for limiting genital ulcer disease and HIV-1 infection in men in sub-Saharan Africa. Genitourin Med 1993, 69:297-300.
2. Gray R, Azire J, Serwadda D, et al.: Male circumcision and the risk of sexually transmitted infections and HIV in Rakai, Uganda. AIDS 2004, 18:2428-2430.
3. Hodges FM: The antimasturbation crusade in antebellum American medicine. J Sex Med 2005, 2:722-731.
4. American Academy of Pediatrics: Report of the Task Force on Circumcision. Pediatrics 1989, 84:388-391.
5. Auvert B, Taljaard D, Lagarde E, et al.: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2:e298.
6. Bailey RC, Moses S, Parker CR, et al.: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007, 369:643-656.
7. Gray RH, Kigozi G, Serwadda D, et al.: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369:657-666.
8. Moses S, Bradley JE, Nagelkerke NJ, et al.: Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol 1990, 19:693-697.
9. Moses S, Plummer FA, Bradley JE, et al.: The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis 1994, 21:201-210.
10. Siegfried N, Muller M, Deeks J, et al.: HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis 2005, 5:165-173.
11. Auvert B, Buve A, Lagarde E, et al.: Male circumcision and HIV infection in four cities in sub-Saharan Africa. AIDS 2001, 15(Suppl 4):S31-S40.
12. Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000, 14:2361-2370.
13. Schoen EJ, Oehrli M, Colby C, Machin G: The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000, 105:E36.
14. Bailey RC: Scaling up circumcision programmes: the road from evidence to practice [plenary]. Presented at 4th Annual International AIDS Society Conference. Sydney, Australia; July 24, 2007.
15. Moses S, Bailey RC, Ronald AR: Male circumcision: assessment of health benefits and risks. Sex Transm Infect 1998, 74:368-373.
16. Fink AJ: A possible explanation for heterosexual male infection with AIDS. N Engl J Med 1986, 315:1167.
17. Gray RH, Kiwanuka N, Quinn TC, et al.: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 2000, 14:2371-2381.
18. Lavreys L, Rakwar JP, Thompson ML, et al.: Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect Dis 1999, 180:330-336.
19. Cameron DW, Simonsen JN, D'Costa LJ, et al.: Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989, 2:403-407.
20. Reynolds SJ, Shepherd ME, Risbud AR, et al.: Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 2004, 363:1039-1040.
21. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al.: Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995, 172:1486-1491.
22. Singh-Grewal D, Macdessi J, Craig J: Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 2005, 90:853-858.
23. Castellsague X, Bosch FX, Munoz N, et al.: Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002, 346:1105-1112.
24. Castellsague X, Bosch FX, Munoz N: The male role in cervical cancer. Salud Publica Mex 2003, 45(Suppl 3): S345-S353.
25. Bailey RC: Male circumcision: The road from evidence to practice [plenary]. Presented at the 4th Annual International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Sydney, Australia; July 22-25, 2007.
26. Tobian A, Serwadda D, Quinn T, et al.: Trial of male circumcision: prevention of HSV-2 in men and vaginal infections in female partners, Rakai, Uganda [abstract 28LB]. Presented at the 15th Annual Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3-6, 2008.
27. Kigozi G: The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda [presentation WEAC101]. Presented at the 4th International AIDS Society Meeting. Sydney, Australia; July 25, 2007.
28. Statement on Kenyan and Ugandan Trial Findings Regarding Male Circumcision and HIV. Joint Statement by the World Health Organization (WHO), the United Nations Population Fund (UNFPA), the United Nations Children's Fund (UNICEF), the World Bank and the UNAIDS Secretariat. Available at http://www.who.int/mediacentre/news/statements/2006/s18/en/ index.html. Accessed December 11, 2007.
29. Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006, 3:e517.
30. Gray RH, Li X, Kigozi G, et al.: The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007, 21:845-850.
31. Sawires SR, Dworkin SL, Fiamma A, et al.: Male circumcision and HIV/ AIDS: challenges and opportunities. Lancet 2007, 369:708-713.
32. Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007, 7:16.
33. Williams BG, Lloyd-Smith JO, Gouws E, et al.: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006, 3:e262.
34. Rennie S, Muula AS, Westreich D: Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. J Med Ethics 2007, 33:357-361.
35. Bailey RC, Plummer FA, Moses S: Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis 2001, 1:223-231.
36. Mattson CL, Bailey RC, Muga R, et al.: Acceptability of male circumcision and predictors of circumcision preference among men and women in Nyanza Province, Kenya. AIDS Care 2005, 17:182-194.
37. Lagarde E, Dirk T, Puren A, et al.: Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. AIDS 2003, 17:89-95.
38. Scott BE, Weiss HA, Viljoen JI: The acceptability of male circumcision as an HIV intervention among a rural Zulu population, Kwazulu-Natal, South Africa. AIDS Care 2005, 17:304-313.
39. Lukobo MD, Bailey RC: Acceptability of male circumcision for prevention of HIV infection in Zambia. AIDS Care 2007, 19:471-477.
40. Kebaabetswe P, Lockman S, Mogwe S, et al.: Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect 2003, 79:214-219.
41. Harrison R: Circumcision makes a comeback io Swaziland. The Swazi Observer. March 6, 2006.
42. Meissner O, Buso DL: Traditional male circumcision in the Eastern Cape - scourge or blessing? S Afr Med J 2007, 97:371-373.
43. Wawer M, Kigozi G, Serwadda D, et al.: Trial of male circumcision in HIV-positive men, Rakai, Uganda: Effects in HIV-positive men and in women partners [abstract 33LB]. Presented at the 15th Annual Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3-6,2008.
44. Gray R, Wawer M, Thoma M, et al.: Male circumcision and the risks of female HIV and sexually transmitted infections acquisition in Rakai, Uganda [abstract 128]. Presented at the 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO; February 5-8, 2006.
45. Turner AN, Morrison CS, Padian NS, et al.: Male circumcision and women's risk of incident chlamydial, gonococcal and trichomonal infections. [abstract 449]. Presented at the 17th Meeting of the International Society for Sexually Transmitted Diseases Research. Seattle, Washington; July 30, 2007.
46. Lajous M, Mueller N, Cruz-Valdez A, et al.: Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005, 14:1710-1716.
47. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, et al.: Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006, 119:1934-1939.
48. Hernandez BY, Wilkens LR, Zhu X, et al.: Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008.
49. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al.: Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2005, 39:82-89.
50. Grulich AE, Hendry O, Clark E, et al.: Circumcision and male-to-male sexual transmission of HIV. AIDS 2001, 15:1188-1189.
51. Klausner J, Kent C, Kohn R: Male circumcision in STD clinic patients, San Francisco, 1996-2005. Presented at the 2006 National STD Prevention Conference. Jacksonville, FL; May 8-11, 2006.
52. Kreiss JK, Hopkins SG: The association between circumcision status and human immunodeficiency virus infection among homosexual men. J Infect Dis 1993, 168:1404-1408.
53. Varghese B, Maher JE, Peterman TA, et al.: Reducing the risk of sexual HIV transmission: Quantifying the per-act-risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002, 29:38-43.
54. Templeton DJ, Jin F, Prestage GP, et al.: Circumcision status and risk of HIV seroconversion in the HIM cohort of homosexual men in Sydney [abstract WEAC103]. Presented at the 4th Annual International AIDS Society Conference. Sydney, Australia; July 25, 2007.
55. Millett GA, Ding H, Lauby J, et al.: Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities. Acquir Immune Defic Syndr 2007, 46:643-650.
56. Sullivan PS, Kilmarx PH, Peterman TA, et al.: Male circumcision for prevention of HIV transmission: What the new data mean for HIV prevention in the United States. PLoS Med 2007, 4:e223.
57. Guanira J, Lama JR. Goicochea P, et al.: How willing are gay men to "cut off" the epidemic? Circumcision among MSM in the Andean region [abstract WEAC102]. Presented at the 4th Annual International AIDS Society conference. Sydney, Australia; July 25, 2007.
58. Auvert B, Kahn J, Korenromp E, et al.: Cost of the roll-out of male circumcision in sub-Saharan Africa [abstract WEAC105]. Presented at the 4th International AIDS Society Meeting. Sydney, Australia; July 25, 2007.